Cannabis and Hemp Industry Investment News
The trio of companies will buy up to C$5 million of Thomas Elcome’s hemp crop for five years starting in 2019 The three companies earlier struck a dea...
Canntab Therapeutics () Chief Financial Officer Richard Goldstein sat down with Steve Darling from Proactive Investors Vancouver to discuss the news t...
A placebo-controlled study led by Dr Don Garbuz will test the effectiveness of the company’s Canntab product in reducing the need for opioids after kn...
The company said it reached a milestone in its development of an oral extended-release formulation for cannabinoids Canntab has taken an important ste...
The company is developing advanced pharmaceutical grade formulations of cannabinoids The company is developing advanced pharmaceutical grade formulati...
